Gene · 4653
Papers2,007
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,007
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Incision of the pre-Descemet layer and Descemet membrane affects outflow facility: ex-vivo studies on a human eye perfusion model. | Front Med (Lausanne) | 2026 | 41728614 | PubTator, text mining | PubMed |
| Disease modeling of myocilin mutation-dependent normal tension glaucoma: human retinal ganglion cell susceptibility to unfolded protein response and mTOR signaling. | Stem Cells | 2026 | 41712748 | PubTator, text mining | PubMed |
| Effects of ascorbic acid on trabecular meshwork gene expression and collagen secretion. | BMJ Open Ophthalmol | 2026 | 41692493 | PubTator, text mining | PubMed |
| Establishment of insulin resistance-related ten-gene signature in endometrial cancer and identification of ACTL8 as a prognostic and immunological biomarker. | Clin Transl Oncol | 2026 | 41670819 | PubTator, text mining | PubMed |
| Molecular Portraits of Aqueous Humor in Primary and Pseudoexfoliative Open-Angle Glaucoma. | J Proteome Res | 2026 | 41665634 | PubTator, text mining | PubMed |
| Phosphatidylcholine modulates trabecular meshwork resilience to glaucomatous injury via regulation of TGFBR3 signaling. | Int J Surg | 2026 | 41664644 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the impact of concurrent, resistance, and endurance training on skeletal muscle. | PLoS One | 2026 | 41637404 | PubTator, text mining | PubMed |
| Time-Dependent Glucocorticoid-Induced Transcriptomic Changes in Human Trabecular Meshwork and Schlemm's Canal Cells. | Invest Ophthalmol Vis Sci | 2026 | 41636427 | PubTator, text mining | PubMed |
| Loss of Cathepsin K Impairs Collagen Biogenesis and Enhances Actin Polymerization in Trabecular Meshwork. | Invest Ophthalmol Vis Sci | 2026 | 41615370 | PubTator, text mining | PubMed |
| A multi-algorithm machine learning framework identifies FGD5, LRRC36, C8B, and MYOC as novel diagnostic biomarkers in lung adenocarcinoma. | Discov Oncol | 2026 | 41604006 | PubTator, text mining | PubMed |
| AAV-DJ-Mediated MYOC Silencing as a Gene Therapy Approach for Myocilin-Associated Glaucoma. | Invest Ophthalmol Vis Sci | 2026 | 41569028 | PubTator, text mining | PubMed |
| Digoxin Attenuates Ocular Hypertension and Protects Trabecular Meshwork Cells via Ferroptosis Inhibition. | Invest Ophthalmol Vis Sci | 2026 | 41563015 | PubTator, text mining | PubMed |
| A Pilot Study Profiling Aqueous Humor-Derived Exosomal MicroRNA in Primary Open-Angle and Exfoliation Glaucoma. | Ophthalmol Sci | 2026 | 41552653 | PubTator, text mining | PubMed |
| Enhanced and Classical MD Simulations Map Aggregation-Prone Regions in the Olfactomedin Domain of Myocilin. | J Chem Inf Model | 2026 | 41442590 | PubTator, text mining | PubMed |
| Design, synthesis, and biological properties exhibited by 1,2,3-triazole based Grp94-selective inhibitors. | Eur J Med Chem | 2026 | 41351922 | PubTator, text mining | PubMed |
| VIRE: a metagenome-derived, planetary-scale virome resource with environmental context. | Nucleic Acids Res | 2026 | 41316726 | PubTator, text mining | PubMed |
| Diagnostic accuracy of next generation sequencing-based genetic research for primary glaucoma: A systematic review and meta-analysis. | Surv Ophthalmol | 2026 | 41043518 | PubTator, text mining | PubMed |
| Long-Term Follow-Up on a Juvenile Open-Angle Glaucoma Pedigree with a Novel EFEMP1 Mutation (c.1313, p.Tyr438Cys). | Ophthalmol Glaucoma | 2026 | 40876537 | PubTator, text mining | PubMed |
| Genetic variants through exome sequencing in Spanish patients affected by primary congenital glaucoma and juvenile open-angle glaucoma. | Mol Vis | 2025 | 41867382 | PubTator, text mining | PubMed |
| Editorial: Cellular contributors and consequences of protein misfolding and aggregation. | Front Mol Biosci | 2025 | 41562116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4653/papers?page=2